Search results
BMO raises Scholar Rock shares target on SAPPHIRE trial optimism By Investing.com
Investing.com· 6 days agoOn Thursday, BMO Capital Markets adjusted its outlook on Scholar Rock (NASDAQ:SRRK) shares,...
Rezolute announces public offering of common stock By Investing.com
Investing.com· 5 days agoRezolute , Inc. (NASDAQ:RZLT), a biopharmaceutical company specializing in treatments for rare...
Merus N.V. VP controller Harry Shuman sells shares worth over $475,000 By Investing.com
Investing.com· 6 days agoIn a recent transaction, Harry Shuman, the VP Controller and Principal Accounting Officer (PAO) of...
How do I apply for a part-time position in a full-time field? Ask HR
USA TODAY via Yahoo News· 21 hours agoLead by example by taking time off yourself, to show that it’s essential and acceptable. Implement flexible or summer hours, allowing employees to have shorter workdays or extended weekends ...
Westchester DA primary candidates answer questions about bail reform, public safety
Lohud | The Journal News via Yahoo News· 1 day agoBut we do need to strike a balance, and use data to better inform the discretion judges have been...
Yigal Nochomovitz Just Trimmed Price Target for Shattuck Labs, Inc. (NASDAQ:STTK)
Insider Monkey via Yahoo Finance· 10 hours agoWe recently compiled a list of the Wall Street Analysts Just Trimmed Price Targets for These 10...
Lixte Biotechnology inks deal for cancer drug trial By Investing.com
Investing.com· 5 days agoLixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) has entered into a significant agreement with the...
5 Growth Strategies Every Leader Should Know About | Entrepreneur
Entrpreneur· 17 hours agoThis required my focus on identifying and establishing clear goals, ensuring everyone was on the...
Canaccord maintains Buy rating on Akero stock, cites drug candidate 'Efruxifermin' By Investing.com
Investing.com· 7 days agoOn Wednesday, Canaccord Genuity (TSX:CF) expressed continued optimism for Akero Therapeutics...
The US Air Force's next-gen stealth fighter faces an uncertain future amid modernization cost woes
Business Insider· 11 hours agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...